跳至主要内容
临床试验/EUCTR2009-018010-18-AT
EUCTR2009-018010-18-AT进行中(未招募)不适用

Multiple-dose Pharmacokinetics of Doripenem during continuous venovenous hemodiafiltration and molecular adsorbent recirculating system in ICU patients and during hemodialysis in longterm hemodialysis patients.

Medizinische Universität Wien, Univ.Klinik f.Innere Medizin I,Abt. f. Infektionen u.Tropenmedizin0 个研究点开始时间: 2010年4月13日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • a)Age >18 years
  • b)Suspected or proven bacterial infection requiring parenteral antibiotic therapy.
  • c)Organ replacement therapy (MARS, CVVHDF or HD)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • a)Known hypersensitivity to doripenem or other carbapenems, or severe hypersensitivity (anaphylactic reaction) to beta-lactam antibacterial agents.
  • b)An expected survival of less than two days.
  • c)Known pregnancy
  • d)Coadministration of valproic acid or probenecid, which cannot be discontinued for the duration of the study
  • e)Doripenem as monotherapy for resistent species or fungal infections.
  • f)Other reasons oposing the study participation on the discretion of the investigators.

研究者

发起方
Medizinische Universität Wien, Univ.Klinik f.Innere Medizin I,Abt. f. Infektionen u.Tropenmedizin

相似试验